Ann: Update on Galderma Contracts, page-71

  1. 296 Posts.
    The position on the list has no relevance. The percentage of the stock is the only relavent number. Still over 11% is short based on your intel. It's been around 11% to 12% since the Glaucus report came out. Seems that the shorts have stayed in the game until at least this point anyway.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.